Overview

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and safety of clobetasol propionate 0.05% (Clobex®) spray compared to clobetasol propionate 0.05% (Olux®) foam.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Clobetasol